Science 37 Holdings, Inc.

Science 37 Holdings, Inc. (Nasdaq: LSAQ) is the combined company formed through the business combination of LifeSci Acquisition 2 Corp and Science 37, a decentralized clinical trial technology platform serving the life sciences sector. LifeSci Acquisition 2 Corp, sponsored by LifeSci Capital LLC, completed its initial public offering in 2020 with a focus on healthcare and life sciences targets. The S-1/A registration statement amendment filed on January 20, 2022 reflects post-merger registration activity for the combined entity, which provides technology and services enabling virtual and hybrid clinical trials for biopharmaceutical sponsors and contract research organizations. Sign up at SpacDesk for full filing history, sponsor data, and deal analytics on this transaction and the broader SPAC market.